NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Wall Street Starts Coverage on PLSE and ENGN: What You Need to Know

Mizuho and Jefferies initiate coverage on Pulse Biosciences and enGene, highlighting growth potential, strong clinical data, and upcoming catalysts in biotech.

Wall Street Starts Coverage on PLSE and ENGN: What You Need to Know
Credit: Pulse Biosciences
Already have an account? Sign in.
01/30/2026 · 9:54 AM
ENGN
/ Don't stop with just one post.

Related↓

enGene Upgraded to Strong Buy on Promising Bladder Cancer Data
11/11/2025 · 9:46 AM

enGene Upgraded to Strong Buy on Promising Bladder Cancer Data

Raymond James upgrades enGene to Strong Buy with $27 target as detalimogene shows 62% complete response rate in bladder cancer trial with excellent tolerability.

/ Subscriber only
/ Read more

Feed↓

AST SpaceMobile’s Big 2025: $1.2B Backlog + Massive Satellite Push Sets Stage for 2026
Featured/ 03/02/2026 · 6:17 PM

AST SpaceMobile’s Big 2025: $1.2B Backlog + Massive Satellite Push Sets Stage for 2026

AST SpaceMobile (ASTS) reports $70.9M revenue in 2025 from partners & gov contracts. Q4 beats expectations; plans 45-60 satellites by 2026 for global direct-to-phone broadband.

/ Subscriber only
MongoDB Stock Tumbles After Q1 Guidance Miss
03/02/2026 · 5:53 PM

MongoDB Stock Tumbles After Q1 Guidance Miss

MongoDB's shares plunged 23% after announcing weaker-than-expected Q1 forecasts, despite strong Q4 results.

/ Subscriber only
SoFi CEO Anthony Noto Buys ~$1M in Shares – A Bullish Signal?
03/02/2026 · 5:36 PM

SoFi CEO Anthony Noto Buys ~$1M in Shares – A Bullish Signal?

SoFi Technologies CEO Anthony Noto purchased 56,000 shares worth about $1 million on March 2, 2026, boosting his stake amid recent stock dips.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe